Bottom line
RXL vs SCHLX: the short answer
RXL (ProShares Ultra Health Care) and SCHLX (DWS Health and Wellness Fund) are both etfs.
RXL is cheaper at 0.95% vs 1.06% — a difference of $11 a year per $10,000 invested.
Updated Nov 19, 2026
RXL vs SCHLX side by side
| RXL | SCHLX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | ProShares | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.95% | 1.06% |
| Annual cost per $10k | $95 | $106 |
| 10-yr cost on $10k (prospectus) | $1,305 | $1,294 |
| Max front load | None | 0% |
| 12b-1 fee | — | 0% |
| 1-yr return | +19.7% | — |
| 5-yr return (annualized) | +7.2% | — |
| 10-yr return (annualized) | +12.6% | — |
| Best quarter | +29.7% | — |
| Worst quarter | −28.9% | — |
| Net assets (fund) | $72.1M | $231.8M |
| Number of holdings | 70 | 65 |
| Portfolio turnover | 4% | 2% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
18 of RXL's top 25 holdings also appear in SCHLX's top 25.
| Holding | RXL | SCHLX |
|---|---|---|
| Eli Lilly & Co. | 12.67% | 13.85% |
| Johnson & Johnson | 7.86% | 6.19% |
| AbbVie, Inc. | 5.57% | 4.90% |
| UnitedHealth Group, Inc. | 4.98% | 5.73% |
| Merck & Co., Inc. | 4.26% | 4.85% |
| Thermo Fisher Scientific, Inc. | 2.68% | 3.46% |
| Amgen, Inc. | 2.62% | 2.88% |
| Gilead Sciences, Inc. | 2.41% | 2.78% |
| Intuitive Surgical, Inc. | 2.18% | 2.69% |
| Pfizer, Inc. | 2.15% | 1.17% |
| Abbott Laboratories | 2.15% | 2.39% |
| Bristol-Myers Squibb Co. | 1.68% | 1.50% |
| Danaher Corp. | 1.66% | 2.13% |
| Vertex Pharmaceuticals, Inc. | 1.64% | 2.45% |
| Stryker Corp. | 1.52% | 2.61% |
Source: SEC Form N-PORT
RXL top 10
- Eli Lilly & Co. — 12.67%
- ProShares GENIUS Money Market ETF — 11.81%
- Johnson & Johnson — 7.86%
- AbbVie, Inc. — 5.57%
- UnitedHealth Group, Inc. — 4.98%
- Merck & Co., Inc. — 4.26%
- Repurchase Agreement — 2.91%
- Thermo Fisher Scientific, Inc. — 2.68%
- Amgen, Inc. — 2.62%
- Gilead Sciences, Inc. — 2.41%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between RXL and SCHLX?
RXL (ProShares Ultra Health Care) and SCHLX (DWS Health and Wellness Fund) are both etfs. RXL is cheaper at 0.95% vs 1.06% — a difference of $11 a year per $10,000 invested.
Which is cheaper, RXL or SCHLX?
RXL has the lower expense ratio (0.95%).
Should I own both RXL and SCHLX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.